380
Views
19
CrossRef citations to date
0
Altmetric
Reviews

Assessment of visual function in idiopathic intracranial hypertension

Pages 45-54 | Received 09 May 2010, Accepted 29 Nov 2010, Published online: 16 Feb 2011

References

  • Wall M. Idiopathic intracranial hypertension (pseudotumor cerebri). Curr Neurol Neurosci Rep 2008;8:87–93.
  • Corbett JJ, Savino PJ, Thompson S, et al. Visual loss in pseudotumor cerebri. Arch Neurol 1982;39:461–74.
  • Wall M, George DN. Visual loss in pseudotumor cerebri. Arch Neurol 1987;44:170–5.
  • Wall M, Conway MD, House PH, et al. Evaluation of sensitivity and specificity of spatial resolution and Humphrey automated perimetry in pseudotumor cerebri patients and normal subjects. Invest Ophthalmol Vis Sci 1991;32: 3306–12.
  • Rowe FJ, Sarkies NJ. Assessment of visual function in idiopathic intracranial hypertension. A prospective study. Eye 1998;12:111–8.
  • Rowe FJ, Sarkies NJ. Visual outcome in a prospective study of idiopathic intracranial hypertension. Arch Ophthalmol 1999;117:1571.
  • Wall M, George DN. Idiopathic intracranial hypertension. A prospective study of 50 patients. Brain 1991;114:155–80.
  • Dandy WE. Intracranial pressure without brain tumor: diagnosis and treatment. Ann Surg 1937;106:492–513.
  • Lysak WR, Svien HJ. Long term follow up on patients with diagnosis of pseudotumor cerebri. J Neurosurg 1966;25: 284–7.
  • Johnston I, Paterson A. Benign intracranial hypertension. Part I (Diagnosis and prognosis). Brain 1974;97:289–300.
  • Vassilouthis J, Uttley D. Benign intracranial hypertension. Clinical features and diagnosis using CT and treatment. Surg Neurol 1979;12:389–92.
  • Rush JA. Pseudotumor cerebri; clinical profile and visual outcome in 63 patients. Mayo Clin Proc 1980;55:541–6.
  • Orcutt JC, Page NGR, Sanders MD. Factors affecting visual loss in benign intracranial hypertension. Ophthalmology 1984;91:1303–12.
  • Sorensen PS, Trojaborg W, Gjerris F, Krogsaa B. Visual evoked potentials in pseudotumor cerebri. Arch Neurol 1985;42:150–3.
  • Acheson JF. Idiopathic intracranial hypertension and visual function. Br Med Bull 2006;79–80:233–44.
  • Shah VA, Kardon RH, Lee AG, Corbett JJ, Wall M. Long-term follow-up of idiopathic intracranial hypertension: the Iowa experience. Neurology 2008;70:634–40.
  • Digre KB, Nakamoto BK, Warner JE, Langeberg WJ, Baggalev SK, Katz BJ. A comparison of idiopathic intracranial hypertension with and without papilloedema. Headache 2009;49:185–93.
  • Lepore FE. Unilateral and highly asymmetric papilloedema in pseudotumor cerebri. Neurology 1992;42:676–8.
  • Hayreh SS. Optic disc oedema in raised intracranial pressure. V. Pathogenesis. Arch Ophthalmol 1977;95:1553–65.
  • Maxner CE, Freedman MI, Corbett JJ. Asymmetric papilloedema and visual loss in pseudotumor cerebri. Can J Neurol Sci 1987;14:593–6.
  • Muci-Mendoza R. Unilateral and asymmetric optic disc swelling with intracranial abnormalities. Am J Ophthalmol 1984;97:253.
  • Paton L, Holmes G. The pathology of papilloedema; a histological study of 60 eyes. Brain 1911;3:389–432.
  • Hayreh SS. Pathogenesis of oedema of the optic disc (papilloedema). A preliminary report. Br J Ophthalmol 1964;48:522–42.
  • Hayreh SS. Pathogenesis of oedema of the optic disc [PhD thesis]. London: University of London; 1965.
  • Hayreh SS. Optic disc oedema in raised intracranial pressure. VI. Associated visual disturbances and their pathogenesis. Arch Ophthalmol 1977;95:1566–79.
  • Tso MOM, Hayreh SS. Optic disc oedema in raised intracranial pressure. IV. Axoplasmic transport in experimental papilloedema. Arch Ophthalmol 1977;95:1458–62.
  • Wall M, Hart WM, Burde RM. Visual field defects in idiopathic intracranial hypertension (pseudotumor cerebri). Am J Ophthalmol 1983;96:654–69.
  • Eggers HM, Sanders MD. Acquired optociliary shunt vessels in papilloedema. Br J Ophthalmol 1980;64:267–9.
  • Rodrigues MM, Savino PJ, Schatz NJ. Spheno-orbital meningioma. Am J Ophthalmol 1975;81:666.
  • Baker RS, Buncie JR. Sudden visual loss in pseudotumor cerebri due to central retinal artery occlusion. Arch Neurol 1984;41:1274–6.
  • Lavinsky J, Lavinsky D, Lavinsky F, Frutuoso A. Acquired choroidal folds: a sign of idiopathic intracranial hypertension. Graefes Arch Clin Exp Ophthalmol 2007;245:883–8.
  • Gutgold-Glen H, Kattah JC, Chavis RM. Reversible visual loss in pseudotumor cerebri. Arch Ophthalmol 1984;102:403–6.
  • Trick GL, Vesti E, Tawansy K, Skart B, Gartner J. Quantitative evaluation of papilloedema in pseudotumor cerebri. Invest Ophthalmol Vis Sci 1998;39:1964–71.
  • Chen JY, Taranath DA, Chappell AJ, Brophy BP, Craig JE. Objective monitoring of papilloedema using confocal scanning laser ophthalmoscopy. Clin Exp Ophthalmol 2007;35:863–5.
  • Mulholland DA, Craig JJ, Rankin SJ. Use of scanning laser ophthalmoscopy to monitor papilloedema in idiopathic intracranial hypertension. Br J Ophthalmol 1998;82:1301–5.
  • Salgarello T, Falsini B, Tedesco S, Galan ME, Colotto A, Scullica L. Correlation of optic nerve head tomography with visual field sensitivity in papilloedema. Invest Ophthalmol Vis Sci 2001;42:1487–94.
  • Heckmann JG, Faschingbauer F, Lang C, et al. Laser scanning tomography measurement of the extent of papilloedema in the follow-up examination of patients with idiopathic intracranial hypertension. J Neurosurg 2007;107:543–7.
  • Salgarello T, Tamburrelli C, Falsini B, Giudiceandrea A, Colotto A. Optic nerve diameters and perimetric thresholds in idiopathic intracranial hypertension. Br J Ophthalmol 1996;80:509–14.
  • Tamburelli C, Salgarello T, Caputo CG, Giudiceandrea A, Scullica L. Ultrasonographic evaluation of optic disc swelling: comparison with CSLO in idiopathic intracranial hypertension. Invest Ophthalmol Vis Sci 2000;41:2960–6.
  • El-Dairi MA, Holgado S, O'Donnell T, Buckley EG, Asrani S, Freedman SF. Optical coherence tomography as a tool for monitoring pediatric pseudotumor cerebri. J AAPOS 2007;11:564–70.
  • Rebolleda G, Munoz-Negrete FJ. Follow-up of mild papilloedema in idiopathic intracranial hypertension with optical coherence tomography. Invest Ophthalmol Vis Sci 2009;50:5197–200.
  • Rowe FJ. Visual fields via the visual pathway. Oxford: Blackwell Publications.
  • Beck RW, Bergstrom TJ, Lichter PR. A clinical comparison of visual field testing with a new automated perimeter (Humphrey) and the Goldmann perimeter. Ophthalmology 1985;92:77–82.
  • Radhakrishnan K, Sridharan R, Ashok PP, Mousa ME. Pseudotumor cerebri; incidence and pattern in northeastern Libya. Eur Neurol 1986;25:117–24.
  • Krogsaa B, Sorensen PS, Seedorff HH, Trojaborg W, Gjerris F. Ophthalmologic prognosis in benign intracranial hypertension. Acta Ophthalmol Suppl 1985;173:62–4.
  • Radhakrishnan K, Thacker AK, Bohlaga NH, Maloo JC, Gerryo SE. Epidemiology of idiopathic intracranial hypertension; a prospective and case controlled study. J Neurol Sci 1993;116:18–28.
  • Weisberg LA. Benign intracranial hypertension. Medicine 1975;54:197–207.
  • Frisen L, Holme M. Neuro ophthalmology. In: Glaser J, ed. 9th ed. St. Louis, MO: CV Mosby; 1977.
  • Corbett JJ. Problems in the diagnosis and treatment of pseudotumor cerebri. Can J Neurol Sci 1983;10:221–9.
  • Foley J. Benign forms of intracranial hypertension – toxic and otitic hydrocephalus. Brain 1955;78:1–41.
  • Dersh J, Schlezinger NS. Inferior nasal quadrantanopia in pseudotumor cerebri. Arch Neurol 1959;1:695–9.
  • Minckler D, Tso MOM, Zimmerman LE. A light microscopic, autoradiographic study of axoplasmic transport in optic nerve head during ocular hypotony, increased intraocular pressure, and papilloedema. Am J Ophthalmol 1976;82:741–57.
  • Morse PH, Leveille AS, Antel JP, Burch JV. Bilateral juxtapapillary subretinal neovascularisation associated with pseudotumor cerebri. Am J Ophthalmol 1981;91:312–7.
  • Quigley HA, Addicks EM. Regional differences in the structure of the lamina cribrosa and their relation to glaucomatous optic nerve damage. Arch Ophthalmol 1980;99:137–43.
  • Traquair HM. Introduction to clinical perimetry. 6th ed. St. Louis, MO: CV Mosby; 1949.
  • Buchanan TAS, Hoyt WF. Temporal visual field defects associated with nasal hypoplasia of the optic disc. Br J Ophthalmol 1981;65:636–40.
  • Smith TJ, Baker RS. Perimetric findings in pseudotumor cerebri using automated techniques. Ophthalmology 1986;93:887–94.
  • Guidetti B, Giuffre R, Gambacorta D. Follow up study of 100 cases of pseudotumor cerebri. Acta Neurochir 1968;18:259–67.
  • Knight RSG, Fielder AR, Firth JL. Benign intracranial hypertension. Visual loss and optic nerve sheath fenestration. J Neurol Neurosurg Psychiatry 1986;49:243–50.
  • Wall M. Contrast sensitivity testing in pseudotumor cerebri. Ophthalmology 1986;93:4–7.
  • Verplanck M, Kaufman DI, Parson T, Yedavally S, Kodinakis D. Electrophysiology versus psychophysics in the detection of visual loss in pseudotumor cerebri. Neurology 1988;38:1789–92.
  • Buncie JR, Tytla ME. Contrast sensitivity in shunted hydrocephalus. Invest Ophthalmol Vis Sci (Suppl) 1989;30:407.
  • Wall M, Dalali M. Contrast sensitivity, color vision and perimetry in 100 examinations of patients with optic neuropathies and normal Snellen acuity. Doc Ophthalmol Proc Ser 1989;43:59–66.
  • Wall M. Idiopathic intracranial hypertension. Neurol Clin 1991;9:73–95.
  • Kirkham TH, Coupland SG. Abnormal ERG's and VEP's in chronic papilloedema using time difference analysis. Can J Neurol Sci 1981;8:243–9.
  • Rowe FJ. Acquired ocular motility disorders and false localising signs in idiopathic intracranial hypertension. Neuro Ophthalmol 2000;24:445–53.
  • Rowe FJ. Ocular motility disturbances in benign intracranial hypertension. Br Orthop J 1996;53:22–4.
  • Walsh FB, Hoyt WF. Clinical neuro ophthalmology. 3rd ed. Baltimore, MA: Williams and Wilkins Co.1969.
  • Gassel MM. False localizing signs. Arch Neurol 1961;4:70–98.
  • Halpern JI, Gordon WH Jr. Trochlear nerve palsy as a false localizing sign. Ann Ophthalmol 1981;9:53–6.
  • Merikangas JR. Skew deviation in pseudotumor cerebri. Ann Neurol 1978;4:583.
  • Tan H. Bilateral oculomotor palsy secondary to pseudotumor cerebri. Pediatr Neurol 2010;42:141–2.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.